{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:37:10Z","timestamp":1786736230124,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijc.ijc_105_18","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T09:10:17Z","timestamp":1567069817000},"page":"207","source":"Crossref","is-referenced-by-count":3,"title":["Pazopanib efficacy and toxicity in a metastatic sarcoma cohort: Are Indian patients different?"],"prefix":"10.4103","volume":"56","author":[{"given":"Sameer","family":"Rastogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilavarasi","family":"Vanidassane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AsitRanjan","family":"Mridha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rambha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Dhamija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adarsh","family":"Barwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.263023-1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12916-017-0872-y","article-title":"Systemic treatment in advanced soft tissue sarcoma: What is standard, what is new","author":"Frezza","year":"2017","journal-title":"BMC Med"},{"key":"key-10.4103\/0019-509X.263023-2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1470-2045(17)30622-8","article-title":"Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): A randomised controlled phase 3 trial","author":"Seddon","year":"2017","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0019-509X.263023-3","first-page":"1879","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial","author":"van","year":"2012","journal-title":"Lancet"},{"key":"key-10.4103\/0019-509X.263023-4","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1080\/0284186X.2017.1332779","article-title":"Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: Results of the SPIRE study","author":"Gelderblom","year":"2017","journal-title":"Acta Oncol"},{"key":"key-10.4103\/0019-509X.263023-5","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/cncr.29961","article-title":"The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study","author":"Nakamura","year":"2016","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.263023-6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5649\/jjphcs.39.322","article-title":"Risk Factor of the Hand\/foot Skin Reaction Induced by Sorafenib in Patients with Advanced Hepatocellular Carcinoma","author":"Odanaka","year":"2013","journal-title":"Iryo Yakugaku Jpn J Pharm Health Care Sci"},{"key":"key-10.4103\/0019-509X.263023-7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/0284186X.2016.1265666","article-title":"Assessment of ethnic differences in sunitinib outcome between Caucasian and Asian patients with metastatic renal cell carcinoma: A meta-analysis","author":"Liu","year":"2017","journal-title":"Acta Oncol"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:39:12Z","timestamp":1786732752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_105_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["263023"],"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_105_18","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}